Kyorin Pharmaceutical Co., Ltd. and BioLeap Enter Research Collaboration
1/9/2012 6:30:16 AM
More...
|
Kyorin Pharmaceutical Co., Ltd. and Eisai Company, Ltd. (ESALY.PK) Sign License Agreement for Development and Marketing of Uritos(R) Tablets in China, India, Sri Lanka and ASEAN Countries
9/29/2009 10:31:59 AM
More...
|
Skyepharma PLC (SKYE) Announces Exclusive License Agreement with Kyorin Pharmaceutical Co., Ltd. for Development and Distribution of Flutiform(TM) in Japan
4/22/2008 10:20:58 AM
More...
|
Bristol-Myers Squibb Company (BMY) To Stop Sale, Manufacture Of Antibiotic Tequin
5/2/2006 11:15:39 AM
More...
|
Kyorin Pharmaceutical Co., Ltd. To Reorganize Its Group Businesses In October
4/21/2006 10:33:53 AM
More...
|
ActivX Biosciences, Inc./Kyorin Pharmaceutical Co., Ltd. Begins First U.S. Phase I Study For Novel Anti-Diabetic Drug
3/15/2006 10:19:54 AM
More...
|
Kyorin Pharmaceutical Co., Ltd. Licenses Immunosuppressant Drug To Novartis Corporation (NVS)
2/16/2006 10:23:43 AM
More...
|
Dainippon Pharmaceutical And Kyorin Pharmaceutical Co., Ltd. To Collaborate In Development Of Drug Candidate For Diabetic Complication
10/19/2005 5:13:06 PM
More...
|
ActivX Biosciences, Inc. Announces Expansion Of Strategic Collaboration Agreement With Pfizer Inc. (PFE) With Multiple Discovery And Developmental Stage Projects
10/19/2005 5:12:40 PM
More...
|
ActivX Biosciences, Inc. Announces Closing Of Acquisition By Kyorin Pharmaceutical Co., Ltd.
10/19/2005 5:12:36 PM
More...
|
|